Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Silke Kapp‐Schwoerer et al.|Journal of Clinical Oncology|2019Cited by 111
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemiaLeo Ruhnke, Christoph Röllig, Marius Bill et al.|Blood Advances|2024Cited by 17